Table 3.
H1: Mφ ≠ Mφ + B. melitensis = Mφ + B. neotomae = Mφ + B. ovis | |||||||||
---|---|---|---|---|---|---|---|---|---|
Probe set | Entrez gene | SLRa |
Average ± SEM | EBarrays probability | Gene symbol | Gene product | Additional statisticsc | ||
Mb | Nb | Ob | |||||||
Small GTPase mediated signal transduction | |||||||||
97415_at | 19340 | −2.6 | −2.0 | −3.2 | −2.6 ± 0.3 | 0.866 | Rab3d | RAB3D, member RAS oncogene family | b, c |
97227_at | 14673 | −2.2 | −2.5 | −1.9 | −2.2 ± 0.3 | 0.807 | Gna12 | Guanine nucleotide binding protein, alpha 12 | a |
97549_at | 12632 | −2.1 | −2.2 | −1.9 | −2.1 ± 0.3 | 0.662 | Cfl2 | Cofilin 2, muscle | |
93850_at | 29875 | −2.7 | −2.0 | −1.3 | −2.0 ± 0.4 | 0.494 | Iqgap1 | IQ motif containing GTPase activating protein 1 | |
Cell proliferation | |||||||||
161417_r_at | 18109 | −2.5 | −2.8 | −2.5 | −2.6 ± 0.5 | 0.968 | Mycn | V-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | |
93943_f_at | 12193 | −2.5 | −2.4 | −2.4 | −2.4 ± 0.5 | 0.925 | Zfp36l2 | Zinc finger protein 36, C3H type-like 2 | |
93713_at | 20416 | −2.5 | −2.7 | −2.2 | −2.5 ± 0.3 | 0.914 | Shc1 | Src homology 2 domain-containing transforming protein C1 | |
92300_at | 17428 | −2.4 | −2.0 | −2.9 | −2.4 ± 0.3 | 0.889 | Mnt | Max binding protein | c |
99076_at | 353187 | −2.2 | −1.7 | −2.8 | −2.3 ± 0.3 | 0.786 | Nr1d2 | Nuclear receptor subfamily 1 group D member 2 | c |
101571_g_at | 16010 | −2.0 | −1.7 | −3.0 | −2.3 ± 0.2 | 0.685 | Igfbp4 | Insulin-like growth factor binding protein 4 | |
99024_at | 17122 | −2.0 | −1.8 | −2.2 | −2.0 ± 0.3 | 0.557 | Mad4 | Max dimerization protein 4 | |
100444_at | 12568 | −2.4 | −1.9 | −1.6 | −2.0 ± 0.4 | 0.520 | Cdk5 | Cyclin-dependent kinase 5 | |
Carboxylic acid metabolism | |||||||||
93320_at | 12894 | −3.4 | −1.9 | −3.1 | −2.8 ± 0.4 | 0.663 | Cpt1a | Carnitine palmitoyltransferase 1a, liver | c |
96799_at | 30839 | −2.7 | −2.2 | −2.3 | −2.4 ± 0.3 | 0.897 | Fbxw5 | F-box and WD-40 domain protein 5 | |
96126_at | 20397 | −2.3 | −2.4 | −2.0 | −2.2 ± 0.2 | 0.704 | Sgpl1 | Sphingosine phosphate lyase 1 | |
94405_at | 21366 | −2.7 | −1.5 | −1.7 | −2.0 ± 0.2 | 0.444 | Slc6a6 | Solute carrier family 6 (neurotransmitter transporter, taurine), member 6 | |
Response to external stimulus | |||||||||
101433_at | 15064 | −2.4 | −2.4 | −2.4 | −2.4 ± 0.3 | 0.918 | Mr1 | Major histocompatibility complex, class I-related | |
104228_at | 668701 | −2.2 | −2.2 | −2.6 | −2.3 ± 0.4 | 0.865 | EG668701 | Similar to Rap guanine nucleotide exchange factor 2 | |
103250_at | 54722 | −2.7 | −2.1 | −2.0 | −2.3 ± 0.2 | 0.838 | Dfna5h | Deafness, autosomal dominant 5 homolog | |
104372_at | 64296 | −2.6 | −2.2 | −1.9 | −2.2 ± 0.2 | 0.793 | Abhd8 | Abhydrolase domain containing 8 | |
99349_at | 16171 | −1.7 | −2.5 | −2.1 | −2.1 ± 0.3 | 0.681 | Il17a | Interleukin 17A | |
93218_at | 20947 | −2.3 | −2.0 | −1.7 | −2.0 ± 0.4 | 0.573 | Swap70 | SWAP complex protein | |
Protein modification | |||||||||
99643_f_at | 12876 | −3.7 | −3.8 | −2.7 | −3.4 ± 0.4 | 0.949 | Cpe | Carboxypeptidase E | b |
161848_r_at | 19260 | −2.5 | −2.2 | −2.4 | −2.4 ± 0.4 | 0.870 | Ptpn22 | Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | |
92427_at | 21812 | −2.4 | −1.9 | −2.3 | −2.2 ± 0.4 | 0.729 | Tgfbr1 | Transforming growth factor, beta receptor I | |
99642_i_at | 12876 | −3.0 | −2.1 | −1.3 | −2.2 ± 0.7 | 0.618 | Cpe | Carboxypeptidase E | |
100427_at | 19277 | −2.0 | −1.4 | −2.7 | −2.0 ± 0.3 | 0.552 | Ptpro | Protein tyrosine phosphatase, receptor type, O | b, c |
Transcription from Pol II promoter | |||||||||
104591_g_at | 17260 | −2.4 | −2.9 | −2.5 | −2.6 ± 0.2 | 0.932 | Mef2c | Myocyte enhancer factor 2C | b, c |
104590_at | 17260 | −2.8 | −2.0 | −2.2 | −2.3 ± 0.2 | 0.821 | Mef2c | Myocyte enhancer factor 2C | a, b |
96171_at | 54006 | −2.1 | −1.6 | −2.4 | −2.0 ± 0.2 | 0.580 | Deaf1 | Deformed epidermal autoregulatory factor 1 (Drosophila) | b |
Cytoskeleton organization and biogenesis | |||||||||
95705_s_at | 11461 | −2.2 | −3.1 | −2.4 | −2.6 ± 0.5 | 0.887 | Actb | Actin, beta, cytoplasmic | |
161981_r_at | 14246 | −2.6 | −1.6 | −2.4 | −2.2 ± 0.4 | 0.693 | Flg | Filaggrin | |
Metabolism | |||||||||
94872_at | 57319 | −2.8 | −2.5 | −2.8 | −2.7 ± 0.4 | 0.934 | Smpdl3a | Sphingomyelin phosphodiesterase, acid-like 3A | |
161733_at | 59010 | −2.4 | −2.9 | −2.1 | −2.5 ± 0.3 | 0.919 | Sqrdl | Sulfide quinone reductase-like | |
101972_at | 16541 | −2.8 | −2.4 | −2.5 | −2.6 ± 0.3 | 0.915 | Napsa | Napsin A aspartic peptidase | |
99667_at | 12862 | −2.3 | −2.2 | −2.5 | −2.3 ± 0.5 | 0.878 | Cox6a2 | Cytochrome c oxidase, subunit VI a, polypeptide 2 | |
103538_at | 21386 | −1.8 | −2.1 | −2.5 | −2.1 ± 0.3 | 0.680 | Tbx3 | T-box 3 | |
96035_at | 12039 | −1.7 | −2.0 | −2.4 | −2.0 ± 0.4 | 0.606 | Bckdha | Branched chain ketoacid dehydrogenase E1, alpha polypeptide | |
97560_at | 19156 | −1.4 | −3.0 | −1.7 | −2.0 ± 0.4 | 0.381 | Psap | Prosaposin | |
Cell communication | |||||||||
160932_at | 17973 | −2.6 | −2.6 | −2.6 | −2.6 ± 0.1 | 0.964 | Nck1 | Non-catalytic region of tyrosine kinase adaptor protein 1 | a, b |
97768_at | 13506 | −2.2 | −2.1 | −2.6 | −2.3 ± 0.3 | 0.803 | Dsc2 | Desmocollin 2 | |
Cell growth and/or maintenance | |||||||||
92695_at | 14296 | −2.0 | −1.6 | −2.7 | −2.1 ± 0.3 | 0.658 | Frat1 | Frequently rearranged in advanced T-cell lymphomas | |
103534_at | 15130 | −2.8 | −2.0 | −1.5 | −2.1 ± 0.2 | 0.626 | Hbb-b2 | Hemoglobin, beta adult minor chain | b |
93736_at | 21452 | −2.0 | −2.0 | −2.3 | −2.1 ± 0.3 | 0.606 | Tcn2 | Transcobalamin 2 | |
Miscellaneous classification | |||||||||
96494_at | 75785 | −2.9 | −2.7 | −2.5 | −2.7 ± 0.2 | 0.959 | Klhl24 | Kelch-like 24 (Drosophila) | |
103933_at | 22619 | −2.9 | −1.9 | −2.8 | −2.5 ± 0.2 | 0.895 | Siae | Sialic acid acetylesterase | b |
104299_at | 224454 | −3.0 | −1.9 | −2.5 | −2.5 ± 0.3 | 0.852 | Zdhhc14 | Zinc finger, DHHC domain containing 14 | |
94299_at | 69654 | −2.5 | −2.0 | −2.2 | −2.2 ± 0.2 | 0.788 | Dctn2 | Dynactin 2 | |
162116_r_at | 116891 | −3.0 | −2.7 | −1.7 | −2.5 ± 0.9 | 0.741 | Derl2 | Der1-like domain family, member 2 | |
160934_s_at | 73094 | −3.0 | −2.6 | −1.6 | −2.4 ± 0.5 | 0.692 | Sgip1 | SH3-domain GRB2-like (endophilin) interacting protein 1 | |
104714_at | 105445 | −2.2 | −1.7 | −2.2 | −2.0 ± 0.2 | 0.611 | Dock9 | Dedicator of cytokinesis 9 | |
162075_r_at | 17476 | −2.7 | −1.5 | −3.8 | −2.7 ± 0.4 | 0.551 | Mpeg1 | Macrophage expressed gene 1 | |
96464_at | 140570 | −2.1 | −2.2 | −1.9 | −2.1 ± 0.2 | 0.518 | Plxnb2 | Plexin B2 | |
160905_s_at | 80515 | −2.2 | −2.2 | −2.1 | −2.1 ± 0.3 | 0.735 | A030009 H04Rik | RIKEN cDNA A030009H04 gene | |
97119_at | 99029 | −2.6 | −2.5 | −2.2 | −2.4 ± 0.3 | 0.911 | AI596198 | Expressed sequence AI596198 | |
97752_at | 99358 | −2.0 | −2.1 | −2.8 | −2.3 ± 0.3 | 0.858 | E13001 3N09Rik | RIKEN cDNA E130013N09 gene | |
103748_at | 74440 | −2.9 | −1.6 | −2.1 | −2.2 ± 0.2 | 0.645 | 4933407 C03Rik | RIKEN cDNA 4933407C03 gene | |
94069_r_at | 67163 | −3.4 | −2.3 | −2.2 | −2.6 ± 0.3 | 0.946 | 2610204 L23Rik | RIKEN cDNA 2610204L23 gene |
Signal log ratio = LOG2 (experimental Brucella spp. infected signal/control uninfected signal) ± SEM.
M, N, O indicate Brucella spp. used to infect macrophages B. melitensis, B. neotomae and B. ovis, respectively.
Identified by additional statistical analyses: a, ANOVA P ≥ 0.01; b, SAM delta = 0.05; c, B. abortus microarrays (14).